Issue Date | Title | Author(s) |
2022 | Downregulation of Mir29b-2 Is Associated With Hypertrophic Scarring | Harmanci, D.; Kocak, A. ; Demirdover, C.; Akdoğan, Gül |
2017 | Fibrosis Modulation in Scleroderma by Epigallocatechin-3 | Kocak, A. ; Harmanci, D.; Birlik, M.; Sarioglu, S.; Yilmaz, O.; Cavdar, Z.; Akdoğan, Gül |
2018 | Molecular Mechanisms Mediating Antioxidant Effect of Epigallocatechin-3 in Experimental Scleroderma Model | Kocak, A. ; Harmanci, D.; Birlik, M.; Guner, G. |
2016 | Phd Training in Biomedicine and Health Sciences | Artuk, M.; Harmanci, D.; Akdoğan, Gül |
2021 | Possible Effects of Mir29a Downregulation on Keloid Scar Formation | Harmanci, D.; Kocak, A. ; Demirdover, C. |
2017 | Protective Effects of Epigallocatechin 3 Gallate on Fibrosis in Scleroderma Model | Kocak, A. ; Harmanci, D.; Birlik, M.; Sarioglu, S.; Akdoğan, Gül |
2022 | A Training Strategy From a Research Problem To a Collaborative Research Environment and To Building an Innovation Culture | Harmanci, D.; Uygun, Z. O.; Kocak, A. ; Demirdover, C.; Sagin, F.; Akdoğan, Gül |
2018 | VITAMIN D AND VITAMIN D RECEPTOR IN PATIENTS WITH SCLERODERMA SUBTYPES | Kocak, A. ; Harmanci, D.; Birlik, M.; Guner, G. |